Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
May 10, 2019New data further support use of S-ICD System as first-line therapy for majority of ICD patients
New clinical trial data further support use of Boston Scientific’s EMBLEM S-ICD System as first-line therapy for majority of ICD patients.
-
May 9, 2019Acquisition of lumbar spinal stenosis treatment to expand portfolio of interventional pain therapies
Acquisition of lumbar spinal stenosis treatment to expand portfolio of interventional pain therapies.
-
May 7, 2019
Boston Scientific will participate in the upcoming healthcare conference in May 2019. A live webcast and replay will be available.
-
May 6, 2019New stent system now available for treating patients with deep venous blockages
New stent system now available for treating patients with deep venous blockages.
-
May 1, 2019
Results includes data about Boston Scientific S-ICD, POLARx cryoablation catheter, WATCHMAN device and LUX-Dx insertable cardiac monitor.
-
May 1, 2019
Boston Scientific will participate in the upcoming investor healthcare conference in May 2019. A live webcast and replay will be available.
-
Apr 24, 2019
"With our strong pipeline and category leadership strategy, we are confident in our top tier 2019 outlook,” said CEO Mike Mahoney. Read the April 2019 release.
-
Apr 23, 2019Transcatheter Aortic Valve Replacement Technology for Patients with Severe Aortic Stenosis Designed to Minimize Paravalvular Leakage, Offer Controlled Delivery and Repositionability Post Deployment
Transcatheter aortic valve replacement technology for patients with severe aortic stenosis designed to minimize paravalvular leakage, offer controlled delivery and repositionability post deployment.
-
Apr 16, 2019
The inaccessibility of these products will severely limit treatment options for the 50% of women in the U.S. who will suffer from POP during their lives.
-
Mar 27, 2019
Boston Scientific will webcast its conference call with financial results and business highlights for Q1 ended March 31, 2019.